Drug Development: From Discovery to NDA

Introduction
The time it takes from starting a program to selling a product can vary but is usually estimated to be around 10 years and the total cost associated with bringing a drug to market is widely cited to be at least $850 million. These numbers outline high stakes and whether you are an [...]

Funding Roundup: IRX, Genesis, Inimex, VeraLight and ONCODESIGN

Busy day on the funding side today. Too many to keep up with and I’m pretty sure I missed a couple but, no time for whining:

ONCODESIGN Secures 4.7M in Financing
VeraLight secures $20 million series C financing for a non-invasive diabetes screening system
IRX therapeutics completes $25 million series A preferred stock offering to continue clinical development [...]